Home » Analysts Say Exact Deal Not Vital to Sequenom
Analysts Say Exact Deal Not Vital to Sequenom
Cancer test maker Exact Sciences Corp. rebuffed a buyout bid from genetic analysis product maker Sequenom Inc., and analysts said the purchase isn’t necessary for Sequenom — meaning the company may choose to walk away.
boston.com
boston.com
Upcoming Events
-
07May
-
14May
-
23May
-
30May
-
20Jun
-
21Oct